Incidence and survival of rare cancers in the US and Europe

Author:

Botta Laura1,Gatta Gemma1,Trama Annalisa1,Bernasconi Alice1,Sharon Elad2,Capocaccia Riccardo3ORCID,Mariotto Angela B.4,

Affiliation:

1. Evaluative Epidemiology Unit Fondazione IRCCS Istituto Nazionale Tumori Milan Italy

2. Cancer Therapy Evaluation Program National Cancer Institute Bethesda MD USA

3. Editorial Board Epidemiologia & Prevenzione Castellanza Varese Italy

4. Division of Cancer Control and Population Sciences National Cancer Institute Bethesda MD USA

Funder

European Commission

National Cancer Institute

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Reference25 articles.

1. The burden of rare cancers in the United States

2. Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study

3. Joint Action on Rare Cancers Launch.European Cancer Patient Coalition.http://ecpc.org/Documents/Projects/RARECAREnet. Accessed April 1 2019.

4. European Parliament and the Council of the European Union.Directive 2011/24/EU of the European Parliament and of the Council of 9 March 2011 on the application of patients’ rights in cross‐border healthcare. Official Journal of the European Union n° L 88/45 of 4.4.2011.

5. http://www.rarecarenet.eu/rarecarenet/index.php/cancerlisAccessed September 10 2019.

Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3